Equillium (EQ) Earnings Date & Reports

Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EQ is expected to report earnings to rise 81.25% to -28 cents per share on May 08

Q1'25

Est.

$-0.29

Q4'24

Beat

by $0.15

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.16

Q1'24

Beat

by $0.09

The last earnings report on March 27 showed earnings per share of -15 cents, beating the estimate of -31 cents. With 97.14K shares outstanding, the current market capitalization sits at 14.58M.

View a ticker or compare two or three

Compare

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EQ
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2223 Avenida De La Playa

Phone

+1 858 240-1200

Employees

Web

https://www.equilliumbio.com